Sexual risk behaviour of the first cohort undergoing screening for enrollment into Phase I/II HIV vaccine trials in South Africa

Int J STD AIDS. 2009 Feb;20(2):95-101. doi: 10.1258/ijsa.2008.008207.


We assessed risk behaviour in a heterosexual cohort undergoing prescreening for the first Phase I/II HIV vaccine trials in Soweto. We developed a survey and collected self-reported data from HIV-negative potential volunteers. Of 488 participants, most were single and approximately half were from households with incomes below the poverty level. Males reported higher rates of heavy alcohol use (P < 0.001), marijuana use (P < 0.001) and other recreational drug use (P < 0.01). Males reported more sex partners than females in the previous six months (P < 0.001), as well as more casual/anonymous partners (P < 0.001) and one-night stands (P < 0.001). Multivariate analyses revealed substance use and male gender predicted higher risk behaviours, including <100% condom use with known/suspected HIV-positive partners, having casual/anonymous partners and having more than two partners. For this population, male volunteers may need increased risk-reduction counselling during Phase I/II trials and additional recruitment methods may be necessary to identify high-risk female volunteers for Phase III efficacy trials.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines*
  • Adolescent
  • Adult
  • Clinical Trials, Phase I as Topic*
  • Clinical Trials, Phase II as Topic*
  • Cohort Studies
  • Female
  • HIV Infections / prevention & control
  • Heterosexuality
  • Humans
  • Male
  • Middle Aged
  • Patient Selection*
  • Risk-Taking*
  • Sexual Behavior*
  • South Africa
  • Young Adult


  • AIDS Vaccines